$The serum creatinine to cystatin C ratio predicts bone fracture in patients with type 2 diabetes: The Fukuoka Diabetes Registry$

The serum creatinine to cystatin C ratio predicts bone fracture in patients with type 2 diabetes: The Fukuoka Diabetes Registry

Sarcopenia is involved in the pathogenesis of increased fracture risk associated with diabetes. The serum creatinine to cystatin C (Cr/CysC) ratio has been reported as a surrogate marker for muscle mass. We aimed to prospectively investigate the relationship between the Cr/CysC ratio and fracture ri...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetes research and clinical practice 2018-12, Vol.146, p.202-210
Hauptverfasser:	Komorita, Yuji, Iwase, Masanori, Fujii, Hiroki, Ide, Hitoshi, Ohkuma, Toshiaki, Jodai-Kitamura, Tamaki, Sumi, Akiko, Yoshinari, Masahito, Nakamura, Udai, Kitazono, Takanari
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Cohort study Creatinine - blood Cystatin C Cystatin C - blood Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - complications Female Fracture Fractures, Bone - diagnosis Fractures, Bone - etiology Humans Male Prospective Studies Registries Risk Factors Sarcopenia Sarcopenia - diagnosis Sarcopenia - etiology Serum creatinine Type 2 diabetes
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!